Navigation Links
Lilly Reports Third-Quarter 2013 Results
Date:10/23/2013

Information (Unaudited)(Dollars in millions, except per share data)Nine Months Ended

September 30, 2013Nine Months Ended

September 30, 2012GAAP
Reported

Adjustments

Non-GAAP
Adjusted(a)GAAP
Reported

Adjustments

Non-GAAP
Adjusted(a)Total Revenue

$17,304.3-

$

17,304.3

$16,646.0$

-

$

16,646.0Cost of sales3,521.6-3,521.63,548.2-3,548.2Operating Expenses(b)9,227.9-9,227.99,351.0-9,351.0Asset impairments,
restructuring and other
special charges(c)85.2(85.2)-77.1(77.1)-Other income (expense)(d)509.8(495.4)14.4726.0(787.8)(61.8)Income taxes 1,022.1(158.6)863.51,134.4(288.2)846.2Net income 3,957.3(251.6)3,705.73,261.3(422.5)2,838.8Earnings per share – diluted3.64(0.23)3.412.92(.38)2.54 

(a)We use non-GAAP financial measures that differ from financial statements reported in conformity with U.S. generally accepted accounting principles ("GAAP").  The items that we exclude when we provide non-GAAP measures or expectations are typically highly variable, difficult to predict, and of a size that could have a substantial impact on our reported operations for a period. We believe that these non-GAAP measures provide useful information to investors.  Among other things, they may help investors evaluate our ongoing operations. They can assist in making meaningful period-over-period comparisons and in identifying operating trends that would otherwise be masked or distorted by the items subject to the adjustments. Management uses these non-GAAP measures internally to evaluate the performance of the business, including to allocate resources and to evaluate results relative to incentive compensation targets.  Investors should consider these non-GAAP measures in addition to, not as a substitute for or superior to, measures of financial performance prepared in accordan
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
2. Lilly Declares Fourth-Quarter 2013 Dividend
3. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
4. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
5. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
6. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
7. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
8. Lilly to Present Data Across its Diabetes Portfolio at the 49th European Association for the Study of Diabetes Annual Meeting
9. Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes
10. Dr. Marschall S. Runge Elected to Lilly Board of Directors
11. Lilly Reports Second-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014  Decision Resources Group finds that ... $14 billion in 2013 to over $18.2 billion in 2023 in ... , Germany , Italy , ... and Japan . TNF-alpha inhibitors will remain ... the RA market, but growth will be constrained and patient shares ...
(Date:9/16/2014)... , Sept. 16, 2014   Evana Automation ... custom, automated assembly and test systems, recently received a ... leading medical device manufacturer. The Evana solution will help ... and ergonomics, as well as reduce labor. ... fed to Evana,s robotic assembly cell. The robot will ...
(Date:9/16/2014)... , Sept. 16, 2014 The ... Directors Institute has simultaneously released the NAMCP Medical ... Medical Diagnostics Dossier Template © , which provide ... formats for either medical devices or diagnostics that ... of each of these technology types (instead of ...
Breaking Medicine Technology:The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 2Evana Automation to Supply Robotic Assembly Cell to Leading Medical Device Manufacturer 3NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2
... world-leading developer and marketer of innovative medical technologies for ... Bradford (Brad) Barton as President, ConvaTec U.S.   ... the ConvaTec U.S. organization across the company,s three core ... and Critical Care.   Barton joined ConvaTec ...
... SPRING, Md., Nov. 9, 2010 The U.S. Food ... undergoing computed tomography (CT) brain perfusion scans were accidently ... properly used, the CT scanners did not malfunction. Instead, ... scanners resulted in these overdoses. However, the FDA has ...
Cached Medicine Technology:Bradford Barton Named President, ConvaTec U.S. 2FDA Working to Prevent Radiation Overdoses During CT Scans 2FDA Working to Prevent Radiation Overdoses During CT Scans 3
(Date:9/16/2014)... HORAN, a leading advisor in employee benefits ... as Vice President – Retirement Services. , Paul works ... planning. In addition, he monitors investments, fees and providers ... has been a retirement services industry professional for over ... a Senior Investigator at the Department of Labor facilitates ...
(Date:9/16/2014)... 16, 2014 Since the adoption of ... risen considerably in line with increased investment in R&D ... labels include novel paediatric information and more than 130 ... European countries, there has been 221 changes relating to ... submission of old or new trials in children and ...
(Date:9/16/2014)... 2014 This month’s issue features a ... newly elected chairman, Robert Vail of Vail Automotive in ... further the causes of the state’s franchised new car ... the retail automotive industry’s top names including Jenn Reid ... important to take a “360 view” of the customer ...
(Date:9/16/2014)... 2014 LiveOps, the global leader ... announced today that the company has received a ... the creation of a social learning ecosystem and ... Group honors companies that have successfully developed and ... that have helped companies achieve measurable results. This ...
(Date:9/16/2014)... Hudson County, NJ (PRWEB) September 16, 2014 ... that a leading Bariatric Surgeon, Leigh Montes, MD, ... of Bariatric Surgery at Christ Hospital. Our system ... Bariatric Center, a medical and surgical weight loss ... through the most advanced bariatric surgery procedures, including ...
Breaking Medicine News(10 mins):Health News:Paul Carl Joins HORAN's Retirement Plan Consulting Organization 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 3Health News:September Issue of Car Biz Today Magazine Available Online 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3
... When the Spanish capital Madrid decided to replace the thin ... the kind of move that millions of women// around the ... measures to ban very skinny fashion models and to promote ... international interest, a spokesman for the regional government says. ...
... recent research shows that the translaminar approach to cervical ... percent of those treated. ,In addition ... found to be safer than an alternative method or ... alternative approach, steroids are injected in close proximity to ...
... kick the butt. There will be no escape into outdoor areas ... bill// of British Columbia hits the public. ,The new ... in all indoor public spaces as well as in public doorways, ... accessible by the public. , Says Health Minister George ...
... it comes to health care for our kids, we live ... tougher. That is the underlying message// from three University of ... complete overhaul of the U.S child health care system. ... issue of the journal Health Affairs, Dr. Neal Halfon, director ...
... found two of three newer antipsychotic drugs are more ... older medication, according to a research. ,The ... longstanding Clinical Antipsychotic Trials for Intervention Effectiveness (CATIE). Dr. ... School of Medicine, is the lead author. ...
... specialists have underlined the urgency to uplift end of life care. ... the flaws// in the healthcare system that do not adequately ... ,Our health care systems do not reliably meet the needs of ... write Sydney Dy and Joanne Lynn, two palliative care doctors based ...
Cached Medicine News:Health News:Spain Launches Movement Against Skinny Fashion Models 2Health News:Spain Launches Movement Against Skinny Fashion Models 3Health News:Neck Pain Treatment Safer Without Significant Risk of Paralysis 2Health News:U.S. Child Health System Needs Total Overhaul 2Health News:Study Sheds Light on Value of Newer Antipsychotic Drugs for Schizophrenia 2Health News:Care During Last Phase of Life Needs to Be Uplifted 2
125I radioimmunoassay, Simple extraction procedure, Ready-to-use calibrators, Less than 0.1% crossreactivity with DHEA-SO4, 2-hour single incubation, 37C, Calibration Range: 0.5 30 ng/mL...
Inquire...
EL-RF/3 is for measurement of IgM, IgG, IgA RF with high specificity for rheumatoid arthritis....
Rapid latex slide agglutination assay for the qualitative and semi-quantitative determination of Rheumatoid Factors in human serum....
Medicine Products: